The Centers for Medicare & Medicaid Services (CMS) has released the calendar year (CY) 2023 Medicare Physician Fee Schedule (PFS) proposed rule.
In the rule, CMS proposes to adjust the conversion factor, which is used to determine physician payment rates for specific services, to $33.08 — a decrease of $1.53 compared with CY 2022. The PFS proposed rule includes other provisions important to essential hospitals, related to Medicare reimbursement for telehealth services, behavioral health services, the Medicare Shared Savings Program (MSSP), and the Quality Payment Program (QPP).
Medicare reimburses practitioners under the PFS for a list of telehealth services updated through annual rulemaking. CMS proposes to add permanently three new services to the list of reimbursable telehealth services:
- GXXX1: prolonged inpatient or observation services by physician or other qualified healthcare professional (QHP);
- GXXX2: prolonged nursing facility services by physician or other QHP; and
- GXXX3: prolonged home or residence services by physician or other QHP
CMS proposes to add 53 new services to the list of category 3 telehealth services — certain services that were added during the COVID-19 public health emergency (PHE) and will be reimbursed temporarily by Medicare while it examines utilization data. CMS proposes to pay for category 3 telehealth services until the end of CY 2023.
Through previous rulemaking, CMS temporarily added telehealth services that will be reimbursable through the end of the COVID-19 PHE. In accordance with a requirement of the Consolidated Appropriations Act (CAA) of 2022, CMS will reimburse telehealth services from this list that were not added to the category 3 list for a period of 151 days following the end of the PHE declaration. CMS will continue other telehealth flexibilities, such as the waiver of geographic and originating site restrictions, as well as reimbursement of audio-only services, through the end of this 151-day post-PHE period.
Also in accordance with the CAA of 2022, CMS proposes to delay to 152 days after the end of the PHE implementation of the requirement that a patient have an in-person visit prior to a mental health telehealth service.
Payment for Vaccine Administration
In the CY 2022 PFS final rule, CMS finalized payment rates for the costs of administering Part B vaccines: $40 for COVID-19 vaccine administration and $30 for influenza, pneumococcal, and hepatitis B vaccines. After the expiration of the COVID-19 PHE, CMS will align payment rates for COVID-19 vaccine administration with the other three vaccines. CMS proposes to codify these payment rates, to adjust the rates based on geographic locality using the geographic adjustment factor, and to update payment for vaccine administration annually using the Medicare economic index.
CMS also proposes to continue in CY 2023 paying an additional $35.50 for administering the COVID-19 vaccine in a beneficiary’s home. Finally, CMS clarifies that the policies finalized in the CY 2022 PFS final rule regarding COVID-19 vaccine administration and monoclonal antibody products that are tied to the PHE declaration will continue until the Food and Drug Administration’s emergency use authorization for drugs and biological products is terminated, as opposed to being tied to the end of the COVID-19 PHE declaration under the Public Health Service Act.
Quality Payment Program
Proposals under the Quality Payment Program focus on continuing to develop Merit-based Incentive Payment System (MIPS) Value Pathways (MVPs) and refining the subgroup participation option.
MIPS Value Pathways
The MVP framework compares the performance of similar clinicians who report on the same MVP relevant to a specialty, medical condition, or episode of care. CMS will begin transitioning to MVPs in the 2023 MIPS performance year, with an aim to sunset the traditional MIPS after the end of the 2027 performance and data submission periods.
In addition to the seven MVPs already finalized for the 2023 performance period, CMS proposes five new MVPs in these topic areas:
- advancing cancer care;
- optimal care for kidney health;
- optimal care for patients with episodic neurological conditions;
- supportive care for neurodegenerative conditions; and
- promoting wellness.
MVP scoring policies would align with those used in the traditional MIPS across all performance categories, with few exceptions.
Traditional MIPS Program
CMS proposes updates across the four MIPS performance categories: quality, cost, improvement activities, and promoting interoperability. For the quality performance category, CMS proposes to add nine quality measures for the CY 2023 performance period for a total of 194 quality measures. CMS also proposes to expand the definition of high-priority measures to include health equity–related quality measures.
CMS proposes multiple changes to the promoting interoperability performance category, including changing the public health and clinical data exchange objective, requiring the query of prescription drug monitoring program measure, and revising the health information exchange objective.
CMS proposes that, beginning with the 2023 performance period, facility-based, MIPS-eligible clinicians would be eligible to receive the complex patient bonus, even if they do not submit data for at least one MIPS performance category. CMS also issued a request for information (RFI) on risk indicators for the complex patient bonus formula, including whether to incorporate an area deprivation index (ADI) measure and comments on a future definition of safety net providers for the complex patient bonus.
CMS includes other RFIs on the future of the QPP, including a health equity RFI for the quality performance category and RFIs on advancing digital quality measurement and the Trusted Exchange Framework and Common Agreement.
Medicare Shared Savings Program
CMS proposes numerous changes to the MSSP to incent provider participation in accountable care organizations (ACOs), advance equity within the MSSP, and ensure underserved and rural beneficiaries are included in ACOs. For the first time, CMS proposes to offer upfront shared savings payments, which would be available to eligible, low-revenue ACOs that are new to the MSSP and inexperienced with Medicare ACO initiatives. The advance investment payment would consist of an initial $250,000 payment, plus quarterly payments over the first two years of the five-year agreement period. The exact amount of the quarterly payments would be determined on the risk factors–based scores of beneficiaries assigned to the ACO. The risk factors–based score of each beneficiary will be based on whether the beneficiary is dually eligible for Medicare and Medicaid. If the patient is not dually eligible, the score will consider the ADI value of the census block group in which the beneficiary resides.
CMS proposes to implement a health equity adjustment that will be worth up to 10 bonus points toward an ACO’s MIPS quality performance category score. An ACO would be eligible for these bonus points if it demonstrates high performance on all-payer electronic clinical quality measures (eCQMs)/MIPS clinical quality measures (CQMs) and provides care for a higher proportion of underserved or dually eligible beneficiaries.
The proposed rule includes an RFI on using two social determinants of health eCQM/MIPS CQM outcome-oriented measures for ACOs, which would measure providers based on percentage of individuals screened for social needs. These measures are identical to two measures included in the fiscal year 2023 Inpatient Prospective Payment System proposed rule.
CMS also includes changes to promote equity and encourage new ACOs to participate in the MSSP:
- incorporating a sliding scale approach to determine whether an ACO is eligible for shared savings for quality performance;
- providing additional flexibility to organizations new to ACOs by allowing more time to progress to performance-based risk;
- changing quality reporting and quality performance requirements;
- revising the calculation of ACO benchmarks to provide financial incentives for providers to participate in ACOs; and
- reducing ACO administrative burden relating to marketing material requirements, beneficiary notification requirements, and data sharing regulations.
CMS proposes to address the shortage of behavioral health practitioners by allowing licensed professional counselors (LPCs), licensed marriage and family therapists (LMFTs), and other types of behavioral health practitioners to provide behavioral health services under general (rather than direct) supervision. CMS also proposes new codes for bundles of services related to chronic pain management that will improve payment for medically necessary services. Finally, CMS clarifies that opioid treatment programs can bill Medicare for medically reasonable and necessary services provided in mobile units to increase access to individuals affected by homelessness and living in rural areas.
America’s Essential Hospitals is analyzing the proposed rule for comment and will send members a detailed Action Update in the coming days. Comments on the proposed rule are due to CMS by Sept. 6.
Contact Senior Director of Policy Erin O’Malley at email@example.com or 202.585.0127 with questions.